FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386945009> ?p ?o ?g. }

• W4386945009 abstract "Ovarian cancer is a gynecological malignancy with a poor prognosis. For platinum-sensitive relapsed ovarian cancer, maintenance therapy with poly-ADP ribose polymerase (PARP) inhibitors after chemotherapy is considered; however, olaparib treatment does not always lead to sufficient progression-free survival (PFS). This study aimed to identify factors that predict the efficacy of maintenance therapy using olaparib in platinum-sensitive relapsed ovarian cancer.Twenty-seven patients with platinum-sensitive relapsed ovarian cancer, who received initial treatment and showed complete or partial response to prior chemotherapy at our hospital, were included. The primary outcome was the time from the end of previous platinum-based chemotherapy to disease progression (PFS). The Kaplan-Meier method was used to generate time-to-event curves for PFS; multivariate analysis was performed using the Cox proportional hazards regression model.The median PFS was 12 months (95% confidence interval [CI]: 8.3-15.8). Before olaparib administration, the median PFS was 12 months in the <4.1 neutrophil-to-lymphocyte ratio group and 4 months in the ≥4.1 group, with PFS being significantly better in the <4.1 group (log-rank: p = 0.023). When comparing serum cancer antigen 125 (CA125) levels, the median PFS was 13 months in the <18 U/mL group and 6 months in the >18 U/mL group (log-rank: p = 0.022). Multivariate Cox regression analysis revealed that CA125 was the factor affecting PFS (hazard ratio: 4.85; 95% CI: 1.53-15.38).Serum CA125 levels at olaparib initiation in patients with platinum-sensitive relapsed ovarian cancer may predict PFS as an effect of maintenance therapy using olaparib to treat recurrent disease." @default.
• W4386945009 created "2023-09-23" @default.
• W4386945009 creator A5008698000 @default.
• W4386945009 creator A5012461873 @default.
• W4386945009 creator A5019775053 @default.
• W4386945009 creator A5040469059 @default.
• W4386945009 creator A5067577239 @default.
• W4386945009 creator A5081400526 @default.
• W4386945009 creator A5081615805 @default.
• W4386945009 creator A5086960964 @default.
• W4386945009 date "2023-09-21" @default.
• W4386945009 modified "2023-09-28" @default.
• W4386945009 title "Serum <scp>CA125</scp> level as predictors of the efficacy of olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer" @default.
• W4386945009 cites W1982906652 @default.
• W4386945009 cites W1991490883 @default.
• W4386945009 cites W2033707203 @default.
• W4386945009 cites W2060899469 @default.
• W4386945009 cites W2068513410 @default.
• W4386945009 cites W2088050133 @default.
• W4386945009 cites W2117729836 @default.
• W4386945009 cites W2126333580 @default.
• W4386945009 cites W2151050516 @default.
• W4386945009 cites W2160466424 @default.
• W4386945009 cites W2166310305 @default.
• W4386945009 cites W2301964289 @default.
• W4386945009 cites W2345534981 @default.
• W4386945009 cites W2529607059 @default.
• W4386945009 cites W2560862072 @default.
• W4386945009 cites W2611421885 @default.
• W4386945009 cites W2998082025 @default.
• W4386945009 cites W3012975398 @default.
• W4386945009 cites W3027729120 @default.
• W4386945009 cites W3092412842 @default.
• W4386945009 cites W3111820931 @default.
• W4386945009 cites W3200484435 @default.
• W4386945009 cites W4239651622 @default.
• W4386945009 cites W4306661079 @default.
• W4386945009 cites W4381046780 @default.
• W4386945009 cites W4385382395 @default.
• W4386945009 doi "https://doi.org/10.1111/jog.15798" @default.
• W4386945009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37735981" @default.
• W4386945009 hasPublicationYear "2023" @default.
• W4386945009 type Work @default.
• W4386945009 citedByCount "0" @default.
• W4386945009 crossrefType "journal-article" @default.
• W4386945009 hasAuthorship W4386945009A5008698000 @default.
• W4386945009 hasAuthorship W4386945009A5012461873 @default.
• W4386945009 hasAuthorship W4386945009A5019775053 @default.
• W4386945009 hasAuthorship W4386945009A5040469059 @default.
• W4386945009 hasAuthorship W4386945009A5067577239 @default.
• W4386945009 hasAuthorship W4386945009A5081400526 @default.
• W4386945009 hasAuthorship W4386945009A5081615805 @default.
• W4386945009 hasAuthorship W4386945009A5086960964 @default.
• W4386945009 hasBestOaLocation W43869450091 @default.
• W4386945009 hasConcept C104317684 @default.
• W4386945009 hasConcept C121608353 @default.
• W4386945009 hasConcept C126322002 @default.
• W4386945009 hasConcept C143998085 @default.
• W4386945009 hasConcept C182979987 @default.
• W4386945009 hasConcept C185592680 @default.
• W4386945009 hasConcept C207103383 @default.
• W4386945009 hasConcept C2776694085 @default.
• W4386945009 hasConcept C2778822529 @default.
• W4386945009 hasConcept C2779962180 @default.
• W4386945009 hasConcept C2779984678 @default.
• W4386945009 hasConcept C2780427987 @default.
• W4386945009 hasConcept C44249647 @default.
• W4386945009 hasConcept C50382708 @default.
• W4386945009 hasConcept C55493867 @default.
• W4386945009 hasConcept C71924100 @default.
• W4386945009 hasConcept C82381507 @default.
• W4386945009 hasConceptScore W4386945009C104317684 @default.
• W4386945009 hasConceptScore W4386945009C121608353 @default.
• W4386945009 hasConceptScore W4386945009C126322002 @default.
• W4386945009 hasConceptScore W4386945009C143998085 @default.
• W4386945009 hasConceptScore W4386945009C182979987 @default.
• W4386945009 hasConceptScore W4386945009C185592680 @default.
• W4386945009 hasConceptScore W4386945009C207103383 @default.
• W4386945009 hasConceptScore W4386945009C2776694085 @default.
• W4386945009 hasConceptScore W4386945009C2778822529 @default.
• W4386945009 hasConceptScore W4386945009C2779962180 @default.
• W4386945009 hasConceptScore W4386945009C2779984678 @default.
• W4386945009 hasConceptScore W4386945009C2780427987 @default.
• W4386945009 hasConceptScore W4386945009C44249647 @default.
• W4386945009 hasConceptScore W4386945009C50382708 @default.
• W4386945009 hasConceptScore W4386945009C55493867 @default.
• W4386945009 hasConceptScore W4386945009C71924100 @default.
• W4386945009 hasConceptScore W4386945009C82381507 @default.
• W4386945009 hasLocation W43869450091 @default.
• W4386945009 hasLocation W43869450092 @default.
• W4386945009 hasOpenAccess W4386945009 @default.
• W4386945009 hasPrimaryLocation W43869450091 @default.
• W4386945009 hasRelatedWork W2119154902 @default.
• W4386945009 hasRelatedWork W2133235702 @default.
• W4386945009 hasRelatedWork W2203903734 @default.
• W4386945009 hasRelatedWork W2917746345 @default.
• W4386945009 hasRelatedWork W2942893873 @default.
• W4386945009 hasRelatedWork W3040343436 @default.
• W4386945009 hasRelatedWork W3047344552 @default.
• W4386945009 hasRelatedWork W3191066603 @default.

• next